VAERS Explorer
Back to explore

Report #2827719

Received Feb 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
43 yrs
State
LA
Recovered
Unknown
Vaccinated
Feb 14, 2025
Onset
Feb 14, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
IPVPOLIO VIRUS, INACT. (IPOL)SANOFI PASTEURUNKW1A101MOT / LA

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

stated they gave IPOL to a patient and she misread the expiration date 10Feb2026 but she later found out that it was 10 Feb2025 with no adverse event; Initial information received on 14-Feb-2025 regarding an unsolicited valid non-serious case received from a Nurse. This case involves a 43 years old female patient where it was stated they gave IPV (VERO) [IPOL] to a patient and she misread the expiration date 10feb2026 but she later found out that it was 10 feb2025 with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 14-Feb-2025, they gave 0.5 ml dose of suspect IPV (VERO) lot W1A101M via intramuscular route in the left arm to a patient and she misread the expiration date 10feb2026 but she later found out that it was (expiry date- 10 feb2025) with no adverse event (expired product administered) (latency- same day). Action taken- not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.